Completed PHASE4 INTERVENTIONAL 2-arm NCT01723722

Treatment of Neonatal Abstinence Syndrome (HOMENOW)

Treatment of Neonatal Abstinence Syndrome: Evaluation of Efficacy of Phenobarbital in Combination With Either Methadone or Diluted Deodorized Tincture of Opium as Stabilizing and Tapering Regiments

Sponsor: Eastern Maine Medical Center

Conditions Neonatal Abstinence Syndrome

Interventions Diluted Deodorized Tincture of Opium Methadone

Updated 7 times since 2017 Last updated: Nov 5, 2013 Started: Jan 31, 2007 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Neonatal Abstinence Syndrome and is currently completed. Eastern Maine Medical Center leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eastern Maine Medical Center

Data source: Eastern Maine Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangor, United States